These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 28688694)
1. Nutritional changes in patients with locally advanced head and neck cancer during treatment. Arribas L; Hurtós L; Taberna M; Peiró I; Vilajosana E; Lozano A; Vazquez S; Mesia R; Virgili N Oral Oncol; 2017 Aug; 71():67-74. PubMed ID: 28688694 [TBL] [Abstract][Full Text] [Related]
2. Changes in Nutrition Impact Symptoms, Nutritional and Functional Status during Head and Neck Cancer Treatment. Neoh MK; Abu Zaid Z; Mat Daud ZA; Md Yusop NB; Ibrahim Z; Abdul Rahman Z; Jamhuri N Nutrients; 2020 Apr; 12(5):. PubMed ID: 32357529 [TBL] [Abstract][Full Text] [Related]
3. Bioelectrical impedance phase angle as indicator and predictor of cachexia in head and neck cancer patients treated with (chemo)radiotherapy. Stegel P; Kozjek NR; Brumen BA; Strojan P Eur J Clin Nutr; 2016 May; 70(5):602-6. PubMed ID: 26908426 [TBL] [Abstract][Full Text] [Related]
4. Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. Talwar B; Donnelly R; Skelly R; Donaldson M J Laryngol Otol; 2016 May; 130(S2):S32-S40. PubMed ID: 27841109 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy. Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas. Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Daly-Schveitzer N; Bourhis J; Tao Y Anticancer Drugs; 2014 Nov; 25(10):1220-6. PubMed ID: 25144345 [TBL] [Abstract][Full Text] [Related]
7. Pre-therapeutic nutritional assessment for predicting severe adverse events in patients with head and neck cancer treated by radiotherapy. Kono T; Sakamoto K; Shinden S; Ogawa K Clin Nutr; 2017 Dec; 36(6):1681-1685. PubMed ID: 27847115 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis. Teo M; Karakaya E; Young CA; Dyker KE; Coyle C; Sen M; Prestwich RJ Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):647-53. PubMed ID: 23948462 [TBL] [Abstract][Full Text] [Related]
9. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma. Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma. Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532 [TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials. Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131 [TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer. Wang HM; Lin CY; Hsieh CH; Hsu CL; Fan KH; Chang JT; Huang SF; Kang CJ; Liao CT; Ng SH; Yen TC J Formos Med Assoc; 2017 Mar; 116(3):185-192. PubMed ID: 27133181 [TBL] [Abstract][Full Text] [Related]
13. Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial. Lonkvist CK; Lønbro S; Vinther A; Zerahn B; Rosenbom E; Primdahl H; Hojman P; Gehl J BMC Cancer; 2017 Jun; 17(1):400. PubMed ID: 28578654 [TBL] [Abstract][Full Text] [Related]
14. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma]. Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177 [No Abstract] [Full Text] [Related]
15. [The application of induction chemotherapy in the treatment of locally advanced head and neck squamous cell carcinoma]. Zhou L Zhonghua Yi Xue Za Zhi; 2024 Jul; 104(26):2373-2377. PubMed ID: 38978359 [TBL] [Abstract][Full Text] [Related]
16. Quality of Life of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving High-Dose Cisplatin Chemotherapy and Radiotherapy. Visacri MB; Ferrari GB; Dias P; Pimentel R; de Souza CM; Costa AP; de Carvalho Pincinato E; Lima CS; Mazzola PG; Moriel P South Med J; 2015 Jun; 108(6):343-9. PubMed ID: 26079459 [TBL] [Abstract][Full Text] [Related]
17. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial. Fietkau R; Lewitzki V; Kuhnt T; Hölscher T; Hess CF; Berger B; Wiegel T; Rödel C; Niewald M; Hermann RM; Lubgan D Cancer; 2013 Sep; 119(18):3343-53. PubMed ID: 23765693 [TBL] [Abstract][Full Text] [Related]
18. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection. Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313 [TBL] [Abstract][Full Text] [Related]
19. An exploration of factors predicting malnutrition in patients with advanced head and neck cancer. Silander E; Nyman J; Hammerlid E Laryngoscope; 2013 Oct; 123(10):2428-34. PubMed ID: 23918730 [TBL] [Abstract][Full Text] [Related]
20. Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer. Lin YC; Ling HH; Chang PH; Pan YP; Wang CH; Chou WC; Chen FP; Yeh KY Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]